Main clinicopathological features of Study Group 1
| Variable | Study Group 1 |
|---|---|
| (n = 152) | |
| Age: | |
| Mean age ± SEM | 65 ± 0.81 |
| Range | 41–85 |
| pTNM stage: | |
| Stage I | 20 (13.2%) |
| Stage II | 11 (7.2%) |
| Stage III | 111 (73%) |
| Stage IV | 10 (6.6%) |
| Debulking | |
| R0 | 75 (49.4%) |
| R1 | 12 (7.9%) |
| R2 | 65 (42.7%) |
| Vital status of patients | 70 (46.1%) |